Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute
暂无分享,去创建一个
J. Hainsworth | W. Merritt | V. Gian | R. Whorf | L. Finney | B. Dudley | B. S. Dudley | J. Bismayer | Dana S. Thompson